|
|
||||||||
Journal of Applied Physiology, Vol 81, Issue 2 780-788, Copyright © 1996 by American Physiological Society
ARTICLES |
W. R. Hiatt, J. G. Regensteiner, E. E. Wolfel, M. R. Carry and E. P. Brass
Department of Medicine, University of Colorado Health Sciences Center, Denver 80262, USA.
Patients with symptomatic peripheral arterial occlusive disease have a claudication-limited peak exercise performance that is improved with exercise training. The effects of training on skeletal muscle metabolism were evaluated in 26 patients with claudication, randomized into a 12-wk program of treadmill training (enhances muscle metabolic activity in normal subjects), strength training (stimulates muscle hypertrophy in normal subjects), or a nonexercising control group. Gastrocnemius muscle biopsies were performed at rest and before and after training. After 12 wk, only treadmill training improved peak exercise performance and peak oxygen consumption. Treadmill training did not alter type I or type II fiber area and did not increase citrate synthase activity but was associated with an increase in the percentage of denervated fibers (from 7.6 +/- 5.4 to 15.6 +/- 7.5%, P < 0.05). Improvement in exercise performance with treadmill training was associated with a correlative decrease in the plasma (r = -0.67) and muscle (r = -0.59) short-chain acylcarnitine concentrations (intermediates of oxidative metabolism). Patients in the strength and control groups had no changes in muscle histology or carnitine metabolism, but strength-trained subjects had a decrease in citrate synthase activity. Thus treadmill training increased peak exercise performance, but this benefit was associated with skeletal muscle denervation and the absence of a "classic" mitochondrial training response (increase in citrate synthase activity). The present study confirms the relationship between skeletal muscle acylcarnitine content and function in peripheral arterial occlusive disease, demonstrating that the response to treadmill training was associated with parallel improvements in intermediary metabolism.
This article has been cited by other articles:
![]() |
A. HR. Stewart, F. CT. Smith, R. N. Baird, and P. M. Lamont Local Versus Systemic Mechanisms Underlying Supervised Exercise Training for Intermittent Claudication Vascular and Endovascular Surgery, August 1, 2008; 42(4): 314 - 320. [Abstract] [PDF] |
||||
![]() |
I. I. Pipinos, A. R. Judge, J. T. Selsby, Zhen Zhu, S. A. Swanson, A. A. Nella, and S. L. Dodd Basic Science Review: The Myopathy of Peripheral Arterial Occlusive Disease: Part 2. Oxidative Stress, Neuropathy, and Shift in Muscle Fiber Type Vascular and Endovascular Surgery, May 1, 2008; 42(2): 101 - 112. [Abstract] [PDF] |
||||
![]() |
G. M. Andreozzi, A. Leone, R. Laudani, R. Martin, G. Deinit, and V. Cataldi Levo-Propionyl-Carnitine Improves the Effectiveness of Supervised Physical Training on the Absolute Claudication Distance in Patients With Intermittent Claudication Angiology, March 1, 2008; 59(1): 84 - 89. [Abstract] [PDF] |
||||
![]() |
I. I. Pipinos, A. R. Judge, J. T. Selsby, Zhen Zhu, S. A. Swanson, A. A. Nella, and S. L. Dodd The Myopathy of Peripheral Arterial Occlusive Disease: Part 1. Functional and Histomorphological Changes and Evidence for Mitochondrial Dysfunction Vascular and Endovascular Surgery, January 1, 2008; 41(6): 481 - 489. [Abstract] [PDF] |
||||
![]() |
R. G. Mitchell, B. D. Duscha, J. L. Robbins, S. I. Redfern, J. Chung, D. R. Bensimhon, W. E. Kraus, W. R. Hiatt, J. G. Regensteiner, and B. H. Annex Increased levels of apoptosis in gastrocnemius skeletal muscle in patients with peripheral arterial disease Vascular Medicine, November 1, 2007; 12(4): 285 - 290. [Abstract] [PDF] |
||||
![]() |
R. V. Milani and C. J. Lavie The role of exercise training in peripheral arterial disease Vascular Medicine, November 1, 2007; 12(4): 351 - 358. [Abstract] [PDF] |
||||
![]() |
J. Wang, S. Zhou, R. Bronks, J. Graham, and S. Myers Supervised exercise training combined with ginkgo biloba treatment for patients with peripheral arterial disease Clinical Rehabilitation, July 1, 2007; 21(7): 579 - 586. [Abstract] [PDF] |
||||
![]() |
S. A. Badger, C. V. Soong, M. E. O'Donnell, C. A.G. Boreham, and K. E. McGuigan Benefits of a Supervised Exercise Program After Lower Limb Bypass Surgery Vascular and Endovascular Surgery, February 1, 2007; 41(1): 27 - 32. [Abstract] [PDF] |
||||
![]() |
G. V. Reeves, R. R. Kraemer, D. B. Hollander, J. Clavier, C. Thomas, M. Francois, and V. D. Castracane Comparison of hormone responses following light resistance exercise with partial vascular occlusion and moderately difficult resistance exercise without occlusion J Appl Physiol, December 1, 2006; 101(6): 1616 - 1622. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Szuba, R. K Oka, R. Harada, and J. P Cooke Limb hemodynamics are not predictive of functional capacity in patients with PAD Vascular Medicine, August 1, 2006; 11(3): 155 - 163. [Abstract] [PDF] |
||||
![]() |
D. C. Isbell, S. S. Berr, A. Y. Toledano, F. H. Epstein, C. H. Meyer, W. J. Rogers, N. L. Harthun, K. D. Hagspiel, A. Weltman, and C. M. Kramer Delayed Calf Muscle Phosphocreatine Recovery After Exercise Identifies Peripheral Arterial Disease J. Am. Coll. Cardiol., June 6, 2006; 47(11): 2289 - 2295. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. De Vivo, U. Palmer-Kazen, B. Kalin, and E. Wahlberg Risk Factors for Poor Collateral Development in Claudication Vascular and Endovascular Surgery, November 1, 2005; 39(6): 519 - 524. [Abstract] [PDF] |
||||
![]() |
E. P Brass, W. R Hiatt, and S. Green Skeletal muscle metabolic changes in peripheral arterial disease contribute to exercise intolerance: a point-counterpoint discussion Vascular Medicine, November 1, 2004; 9(4): 293 - 301. [Abstract] [PDF] |
||||
![]() |
K. J. Stewart, W. R. Hiatt, J. G. Regensteiner, and A. T. Hirsch Exercise Training for Claudication N. Engl. J. Med., December 12, 2002; 347(24): 1941 - 1951. [Full Text] [PDF] |
||||
![]() |
J. A. Beckman, M. A. Creager, and P. Libby Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management JAMA, May 15, 2002; 287(19): 2570 - 2581. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. M. McGuigan, R. Bronks, R. U. Newton, M. J. Sharman, J. C. Graham, D. V. Cody, and W. J. Kraemer Resistance Training in Patients With Peripheral Arterial Disease: Effects on Myosin Isoforms, Fiber Type Distribution, and Capillary Supply to Skeletal Muscle J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2001; 56(7): B302 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Hiatt Medical Treatment of Peripheral Arterial Disease and Claudication N. Engl. J. Med., May 24, 2001; 344(21): 1608 - 1621. [Full Text] [PDF] |
||||
![]() |
E. P. Brass, W. R. Hiatt, A. W. Gardner, and C. L. Hoppel Decreased NADH dehydrogenase and ubiquinol-cytochrome c oxidoreductase in peripheral arterial disease Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H603 - H609. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Scott-Okafor, K. K. C. Silver, J. Parker, T. Almy-Albert, and A. W. Gardner Lower Extremity Strength Deficits in Peripheral Arterial Occlusive Disease Patients with Intermittent Claudication Angiology, January 1, 2001; 52(1): 7 - 14. [Abstract] [PDF] |
||||
![]() |
E. P Brass and W. R Hiatt Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease Vascular Medicine, February 1, 2000; 5(1): 55 - 59. [Abstract] [PDF] |
||||
![]() |
T. A. Bauer, J. G. Regensteiner, E. P. Brass, and W. R. Hiatt Oxygen uptake kinetics during exercise are slowed in patients with peripheral arterial disease J Appl Physiol, August 1, 1999; 87(2): 809 - 816. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Bhat, W. R. Hiatt, C. L. Hoppel, and E. P. Brass Skeletal Muscle Mitochondrial DNA Injury in Patients With Unilateral Peripheral Arterial Disease Circulation, February 16, 1999; 99(6): 807 - 812. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |